LiliumX is proud to graduate from the Y Combinator startup accelerator in their Winter 2021 batch. With an acceptance rate of approximately 1%, the renowned program provides initial funding and mentorship to promising start-ups. Y Combinator has successfully launched companies such as Ginkgo Bioworks, Airbnb, and Dropbox. The program provided valuable training resources, a wide network of other tech and biotech companies, as well as a $125,000 initial investment.
"We are grateful to be a part of the Y Combinator network, and have thoroughly enjoyed the 3-month remote program. Y Combinator was integral to LiliumX's early successes and has set a steep trajectory for the company."
- Arne Scheu, CEO of LiliumX
For more information, read TechCrunch's Y Combinator Winter 21 news coverage here or see LiliumX’s company overview at Y Combinator’s portfolio here.
Contact Us
United States
Valink Therapeutics Inc
50 Milk Street,
16th floor,
Boston,
MA 02109
United Kingdom
Valink Therapeutics Ltd
Imperial I-Hub,
84 Wood Lane,
London,
W12 0BZ
United Kingdom
Valink Therapeutics Ltd
Imperial I-Hub,
84 Wood Lane,
London,
W12 0BZ
United States
Valink Therapeutics Inc
50 Milk St.,
16th floor,
Boston,
MA 02109